Skip to main content
OpenTrials

Clinical trial condition

Neoplasms by Histologic Type

Explore clinical trials studying Neoplasms by Histologic Type. Study availability and eligibility vary by location and protocol.

30,111 public trials 6,473 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms by Histologic Type trial results

Recruiting

A Phase 1b Study of Lonitoclax + Azacitidine in Acute Myeloid Leukemia Patients

NCT07303660

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • State Budgetary Institution of Healthcare S.P. Botkin Moscow Multidisciplinary Scientific and Clinical Center of the Moscow Health Department Moscow, Russia
  • Medsi group Joint Stock Company Clinical Hospital Krasnogorsk, Moscow Oblast, Russia
  • State Regional Budgetary Healthcare Institution "Novgorod Regional Clinical Hospital" Veliky Novgorod, Novgorod Oblast, Russia
  • Federal State Budgetary Institution "Russian Research Institute of Hematology and Transfusiology of the Federal Medical and Biological Agency" Saint Petersburg, Sankt-Peterburg, Russia
View Trial Details
Recruiting

Study of Iberdomide, Bortezomib, Dexamethasone With Isatuximab Added on Demand for ND-NTE MM Patients

NCT05272826

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • NL Health Services St. John's, Newfoundland and Labrador, Canada
  • QEII Health Science Centre Halifax, Nova Scotia, Canada
  • London Health Sciences Centre London, Ontario, Canada
View Trial Details
Recruiting

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

NCT05536141

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site San Diego, California, United States
  • Research Site Santa Monica, California, United States
  • Research Site Miami, Florida, United States
View all 25 locations
View Trial Details
Recruiting

Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy

NCT05237986

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations
  • Children s Hospital of Los Angeles Los Angeles, California, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • Seattle Children s Hospital Seattle, Washington, United States
View Trial Details
Recruiting

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

NCT06500273

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +13 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Genesis Cancer and Blood Institute Hot Springs, Arkansas, United States
  • Alta Bates Summit Medical Center Berkeley, California, United States
  • City of Hope Duarte, California, United States
View all 83 locations
View Trial Details

Related conditions